BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38728069)

  • 41. [Incidence and prognosis of olfactory and gustatory dysfunctions related to infection of SARS-CoV-2 Omicron strain: a national multi-center survey of 35 566 population].
    Liu MF; Ma RX; Cao XB; Zhang H; Zhou SH; Jiang WH; Jiang Y; Sun JW; Yang QT; Li XZ; Sun YN; Shi L; Wang M; Song XC; Chen FQ; Zhang XS; Wei HQ; Yu SQ; Zhu DD; Ba L; Cao ZW; Xiao XP; Wei X; Lin ZH; Chen FH; Shan CG; Wang GK; Ye J; Qu SH; Zhao CQ; Wang ZL; Li HB; Liu F; Cui XB; Ye SN; Liu Z; Xu Y; Cai X; Hang W; Zhang RX; Zhao YL; Yu GD; Shi GG; Lu MP; Shen Y; Zhao YT; Pei JH; Xie SB; Yu LG; Liu YH; Gu SS; Yang YC; Cheng L; Liu JF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Jun; 58(6):579-588. PubMed ID: 37339898
    [No Abstract]   [Full Text] [Related]  

  • 42. A parosmia severity index based on word-classification predicts olfactory abilities and impairment.
    Hörberg T; Sekine R; Overbeck C; Hummel T; Olofsson JK
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3695-3706. PubMed ID: 36906652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study.
    Hopkins C; Surda P; Whitehead E; Kumar BN
    J Otolaryngol Head Neck Surg; 2020 May; 49(1):26. PubMed ID: 32366299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
    Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemosensory Dysfunction in COVID-19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample.
    Brandão Neto D; Fornazieri MA; Dib C; Di Francesco RC; Doty RL; Voegels RL; Pinna FR
    Otolaryngol Head Neck Surg; 2021 Mar; 164(3):512-518. PubMed ID: 32867582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19.
    Boscolo-Rizzo P; Borsetto D; Fabbris C; Spinato G; Frezza D; Menegaldo A; Mularoni F; Gaudioso P; Cazzador D; Marciani S; Frasconi S; Ferraro M; Berro C; Varago C; Nicolai P; Tirelli G; Da Mosto MC; Obholzer R; Rigoli R; Polesel J; Hopkins C
    JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):729-732. PubMed ID: 32614442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recovery from Covid-19 smell loss: Two-years of follow up.
    McWilliams MP; Coelho DH; Reiter ER; Costanzo RM
    Am J Otolaryngol; 2022; 43(5):103607. PubMed ID: 35987099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the extent and timing of chemosensory impairments during COVID-19 pandemic.
    Cecchetto C; Di Pizio A; Genovese F; Calcinoni O; Macchi A; Dunkel A; Ohla K; Spinelli S; Farruggia MC; Joseph PV; Menini A; Cantone E; Dinnella C; Cecchini MP; D'Errico A; Mucignat-Caretta C; Parma V; Dibattista M
    Sci Rep; 2021 Sep; 11(1):17504. PubMed ID: 34471196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19.
    Burges Watson DL; Campbell M; Hopkins C; Smith B; Kelly C; Deary V
    PLoS One; 2021; 16(9):e0256998. PubMed ID: 34559820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Olfactory dysfunction among patients with COVID-19.
    Alkholaiwi FM; Altamimi AF; Almalki HH; Almughaiseeb FA; Alsubaie SS; Alsayahi HS; Alhijli FW; Alobaishi RS; Agrawal A; Alqahtani ZA; Alotaibi FZ
    Saudi Med J; 2023 Nov; 44(11):1085-1103. PubMed ID: 37926445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.
    Al-Shouli ST; Meo SA; Alafaleq NO; Sumaily KM; Alshehri A; Almutairi A; Eidalsharif A; Alsulami F; Alhanaya S
    Viruses; 2023 May; 15(6):. PubMed ID: 37376577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.
    Mehraeen E; Behnezhad F; Salehi MA; Noori T; Harandi H; SeyedAlinaghi S
    Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):307-312. PubMed ID: 32556781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy.
    Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Lechien JR; Madeddu G; Bonini P; Gardenal N; Cancellieri E; Lazzarin C; Borsetto D; De Vito A; De Riu G; Vaira LA
    Am J Otolaryngol; 2023; 44(5):103944. PubMed ID: 37354725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
    Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
    Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of taste and smell dysfunction in mild and asymptomatic COVID-19 patients during Omicron prevalent period in Shanghai, China: a cross-sectional survey study.
    Wang J; Chen Y; Huang J; Niu C; Zhang P; Yuan K; Zhu X; Jin Q; Ran S; Huang Z
    BMJ Open; 2023 Mar; 13(3):e067065. PubMed ID: 36944468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
    Lechien JR; Chiesa-Estomba CM; De Siati DR; Horoi M; Le Bon SD; Rodriguez A; Dequanter D; Blecic S; El Afia F; Distinguin L; Chekkoury-Idrissi Y; Hans S; Delgado IL; Calvo-Henriquez C; Lavigne P; Falanga C; Barillari MR; Cammaroto G; Khalife M; Leich P; Souchay C; Rossi C; Journe F; Hsieh J; Edjlali M; Carlier R; Ris L; Lovato A; De Filippis C; Coppee F; Fakhry N; Ayad T; Saussez S
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2251-2261. PubMed ID: 32253535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-reported olfactory and gustatory dysfunctions in COVID-19 patients: a 1-year follow-up study in Foggia district, Italy.
    Fortunato F; Martinelli D; Iannelli G; Milazzo M; Farina U; Di Matteo G; De Nittis R; Ascatigno L; Cassano M; Lopalco PL; Prato R
    BMC Infect Dis; 2022 Jan; 22(1):77. PubMed ID: 35065619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study.
    Boscolo-Rizzo P; Spinato G; Hopkins C; Marzolino R; Cavicchia A; Zucchini S; Borsetto D; Lechien JR; Vaira LA; Tirelli G
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5625-5630. PubMed ID: 37715807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.